• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4657933)   Today's Articles (270)   Subscriber (51258)
For: Schmidt M, Görges R, Drzezga A, Dietlein M. A Matter of Controversy: Is Radioiodine Therapy Favorable in Differentiated Thyroid Carcinoma? J Nucl Med 2018;59:1195-1201. [PMID: 29748234 DOI: 10.2967/jnumed.117.191338] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2018] [Accepted: 05/03/2018] [Indexed: 12/31/2022]  Open
Number Cited by Other Article(s)
1
Worapongpaiboon R, Vongsaisuwon M. Breast metastasis of papillary thyroid carcinoma. BMJ Case Rep 2022;15:e251081. [PMID: 35793844 PMCID: PMC9260778 DOI: 10.1136/bcr-2022-251081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/22/2022] [Indexed: 11/03/2022]  Open
2
O'Neill E, Cornelissen B. Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapy. Nucl Med Biol 2022;108-109:44-53. [PMID: 35276447 DOI: 10.1016/j.nucmedbio.2022.02.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2021] [Revised: 02/15/2022] [Accepted: 02/22/2022] [Indexed: 10/18/2022]
3
Schmidt M, Bartenstein P, Bucerius J, Dietlein M, Drzezga A, Herrmann K, Lapa C, Lorenz K, Musholt TJ, Nagarajah J, Reiners C, Sahlmann CO, Kreissl MC. Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear Medicine. Nuklearmedizin 2022;61:87-96. [PMID: 35299276 DOI: 10.1055/a-1783-8154] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
4
Qi L, Zhang W, Ren X, Xu R, Liu C, Tu C, Li Z. Incidence and Predictors of Synchronous Bone Metastasis in Newly Diagnosed Differentiated Thyroid Cancer: A Real-World Population-Based Study. Front Surg 2022;9:778303. [PMID: 35141273 PMCID: PMC8819693 DOI: 10.3389/fsurg.2022.778303] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2021] [Accepted: 01/03/2022] [Indexed: 12/24/2022]  Open
5
Forrer F, Fischer GF, Maas O, Giovanella L, Hoffmann M, Iakovou I, Luster M, Mihailovic J, Petranovic Ovčariček P, Vrachimis A, Zerdoud S, Putora PM. Variations in Radioiodine Therapy in Europe - Decision-Making after Total Thyroidectomy. Oncology 2021;100:74-81. [PMID: 34788758 DOI: 10.1159/000520938] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2021] [Accepted: 10/17/2021] [Indexed: 11/19/2022]
6
Hay ID, Kaggal S, Iniguez-Ariza NM, Reinalda MS, Wiseman GA, Thompson GB. Inability of Radioiodine Remnant Ablation to Improve Postoperative Outcome in Adult Patients with Low-Risk Papillary Thyroid Carcinoma. Mayo Clin Proc 2021;96:1727-1745. [PMID: 33743997 DOI: 10.1016/j.mayocp.2021.02.009] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/13/2020] [Revised: 01/23/2021] [Accepted: 02/11/2021] [Indexed: 12/21/2022]
7
Schmidt M, Antke C, Mattes-György K, Hautzel H, Allelein S, Haase M, Dringenberg T, Schott M, Ehlers M. Radioiodine therapy reduces the frequency of circulating tumour cells in patients with differentiated thyroid cancer. Clin Endocrinol (Oxf) 2021;94:1004-1011. [PMID: 33484159 DOI: 10.1111/cen.14419] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/02/2020] [Revised: 01/08/2021] [Accepted: 01/10/2021] [Indexed: 11/26/2022]
8
Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment? Diagnostics (Basel) 2021;11:diagnostics11030553. [PMID: 33808843 PMCID: PMC8003652 DOI: 10.3390/diagnostics11030553] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2021] [Revised: 03/12/2021] [Accepted: 03/17/2021] [Indexed: 11/16/2022]  Open
9
Li S, Zhang Y, Dong J, Li R, Yu B, Zhao W, Liu J. LINC00893 inhibits papillary thyroid cancer by suppressing AKT pathway via stabilizing PTEN. Cancer Biomark 2021;30:277-286. [PMID: 32924982 DOI: 10.3233/cbm-190543] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
10
Jacobs D, Breen CT, Pucar D, Holt EH, Judson BL, Mehra S. Changes in Population-Level and Institutional-Level Prescribing Habits of Radioiodine Therapy for Papillary Thyroid Cancer. Thyroid 2021;31:272-279. [PMID: 32811347 DOI: 10.1089/thy.2020.0237] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
11
Controversies in Radioiodine Treatment of Low- and Intermediate-risk Thyroid Cancer. Clin Oncol (R Coll Radiol) 2020;33:68-74. [PMID: 33250287 DOI: 10.1016/j.clon.2020.11.009] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2020] [Revised: 10/21/2020] [Accepted: 11/16/2020] [Indexed: 12/23/2022]
12
Fei Y, Qiu Y, Xing Z, Zhao W, Su A, Zhu J. The effects of radioiodine therapy on parathyroid function among patients with papillary thyroid cancer: a retrospective cohort study. Endocrine 2020;70:426-434. [PMID: 32725445 DOI: 10.1007/s12020-020-02429-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/11/2020] [Accepted: 07/18/2020] [Indexed: 02/06/2023]
13
Kurtaran A, Schmoll-Hauer B, Tugendsam C. Aktuelle Diskussion zur risikoadaptierten Therapie des differenzierten Schilddrüsenkarzinoms: Ist weniger (Therapie) wirklich mehr? Wien Med Wochenschr 2019;170:15-25. [DOI: 10.1007/s10354-019-00713-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2018] [Revised: 09/18/2019] [Accepted: 10/15/2019] [Indexed: 12/20/2022]
14
Variations in radioiodine ablation: decision-making after total thyroidectomy. Eur J Nucl Med Mol Imaging 2019;47:554-560. [PMID: 31707428 DOI: 10.1007/s00259-019-04557-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2019] [Accepted: 09/25/2019] [Indexed: 01/29/2023]
15
Estorch M, Mitjavila M, Muros M, Caballero E. Radioiodine treatment of differentiated thyroid cancer related to guidelines and scientific literature. Rev Esp Med Nucl Imagen Mol 2019. [DOI: 10.1016/j.remnie.2018.12.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
16
Estorch M, Mitjavila M, Muros MA, Caballero E. Radioiodine treatment of differentiated thyroid cancer related to guidelines and scientific literature. Rev Esp Med Nucl Imagen Mol 2019;38:195-203. [PMID: 30745131 DOI: 10.1016/j.remn.2018.12.008] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2018] [Accepted: 12/20/2018] [Indexed: 02/02/2023]
17
Pryma DA. Controversies on the Use of Radioiodine in Thyroid Cancer: We Need More and Better Data. J Nucl Med 2018;59:1184-1186. [PMID: 29934408 DOI: 10.2967/jnumed.118.214197] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2018] [Accepted: 06/19/2018] [Indexed: 02/06/2023]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA